Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

Multiple approaches utilizing viral and DNA vectors have shown promise in the development of an effective vaccine against HIV. In this study, an alternative replication-defective flavivirus vector, RepliVax (RV), was evaluated for the delivery of HIV-1 immunogens. Recombinant RV-HIV viruses were eng...

Descripción completa

Detalles Bibliográficos
Autores principales: Giel-Moloney, M., Esteban, M., Oakes, B. H., Vaine, M., Asbach, B., Wagner, R., Mize, G. J., Spies, A. G., McElrath, J., Perreau, M., Roger, T., Ives, A., Calandra, T., Weiss, D., Perdiguero, B., Kibler, K. V., Jacobs, B., Ding, S., Tomaras, G. D., Montefiori, D. C., Ferrari, G., Yates, N. L., Roederer, M., Kao, S. F., Foulds, K. E., Mayer, B. T., Bennett, C., Gottardo, R., Parrington, M., Tartaglia, J., Phogat, S., Pantaleo, G., Kleanthous, H., Pugachev, K. V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934588/
https://www.ncbi.nlm.nih.gov/pubmed/31882800
http://dx.doi.org/10.1038/s41598-019-56550-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934588/
https://www.ncbi.nlm.nih.gov/pubmed/31882800
http://dx.doi.org/10.1038/s41598-019-56550-4

Ejemplares similares